A Versatile Route to Unstable Diazo Compounds via Oxadiazolines and their Use in Aryl-Alkyl Cross-Coupling Reactions. by Greb, Andreas et al.
German Edition: DOI: 10.1002/ange.201710445Photochemistry Hot Paper
International Edition: DOI: 10.1002/anie.201710445
AVersatile Route to Unstable Diazo Compounds via Oxadiazolines
and their Use in Aryl–Alkyl Cross-Coupling Reactions
Andreas Greb+, Jian-Siang Poh+, Stephanie Greed, Claudio Battilocchio, Patrick Pasau,
David C. Blakemore, and Steven V. Ley*
Abstract: Coupling of readily available boronic acids and
diazo compounds has emerged recently as a powerful metal-
free carbon–carbon bond forming method. However, the
difficulty in forming the unstable diazo compound partner in
a mild fashion has hitherto limited their general use and the
scope of the transformation. Here, we report the application of
oxadiazolines as precursors for the generation of an unstable
family of diazo compounds using flow UV photolysis and their
first use in divergent protodeboronative and oxidative C(sp2)@
C(sp3) cross-coupling processes, with excellent functional-
group tolerance.
Diazo compounds represent a highly useful class of
compounds in organic synthesis,[1] for example in cyclopropa-
nation,[2] and heteroatom@H[3] and C@H insertion[4] reactions.
In particular, the reaction of diazo compounds with organo-
boron species has attracted considerable interest over the past
few years, such as in C(sp2)@C(sp3) cross-coupling reactions.[5]
Our previous studies on the flow oxidation of hydra-
zones,[6] showed the effectiveness of utilizing mild conditions
to generate and react diazo compounds with boronic acid. In
particular, this allowed us to intercept the putative unstable
boronic species and thereby enable access to alcohols[6] and
powerful iterative bond-forming processes.[7] Nevertheless,
these studies were limited to the generation of “semi-
stabilized diazo compounds”, bearing either an aryl or vinyl
group adjacent to the diazo moiety. To truly generalize this
concept would require expansion into the elusive realm of
“non-stabilized diazo compounds”, a class of compounds
notorious for their intrinsic instability, toxic/hazardous
nature, and difficulty of preparation (Scheme 1).[1b] Within
this class of reactive intermediates, dialkyl-substituted diazo
compounds pose a major challenge to both access and safely
utilize these reactive species. If a mild method to generate
these non-stabilized diazo compounds could therefore be
realized, a more general method to enable aryl–alkyl cross-
coupling may become possible, along with potential inter-
ception of the intermediate boron species to afford new
reactions.
While a multitude of methods have been developed to
access diazo compounds, few allow the generation of the non-
stabilizedmembers of the family with sufficient generality. An
interesting report byWarkentin et al. in 1989 showed that UV
photolysis of 1,3,4-oxadiazolines at around 300 nm led to
diazoalkanes.[8] Surprisingly, this approach has been largely
overlooked by chemists as a potential route to forming
unstable diazo compounds, and has never before been
engaged in the development of new synthetic methods.
Oxadiazolines are available by a two-step, one-pot procedure
from readily available ketones through condensation of acetic
hydrazide and subsequent PhI(OAc)2-mediated oxidation. In
contrast to alternative diazo precursors such as hydrazones
and nitrosoamides, oxadiazolines were found to be bench-
stable over many months (also see Supporting Information
for differential scanning calorimetry data).
At the outset of our investigation, we decided to exploit
enabling flow technologies to achieve more efficient irradi-
ation compared with a batch reactor,[9] and to avoid the build-
up of hazardous quantities of any unstable diazo com-
pounds.[10–12] Initial studies began with the generation of
oxadiazoline 1, a potential precursor for the cyclic, non-
stabilized diazo compound, 4-diazotetrahydropyran (2 ;
Scheme 2). Passage of an ethereal solution of 1 through
a 10 mL reactor coil held at 10 8C and irradiated at 310 nm
with a 9 WUV lamp, at a 0.125 mLmin@1 flow rate (residence
Scheme 1. Families of diazo compounds.
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time= 80 min) led to the generation of a distinctively red
solution. In-line IR spectroscopic analysis revealed two
important features: a peak at 2040 cm@1 corresponding to
the stretch of a diazo group confirmed the presence of diazo
compound 2 ; in addition, a peak at 1746 cm@1 corresponding
to the C=O stretch of methyl acetate was observed, a useful
gauge of assessing photolytic conversion of the oxadiazolines.
Consequently, we could now efficiently access non-stabilized
diazo compounds using a flow method and then study their
use in C(sp2)@C(sp3) cross-coupling (see the Supporting
Information for optimization results). This procedure is
divergent depending upon the “workup” conditions of the
intermediate boron species.
Using a number of oxadiazolines and readily available
boronic acids (forming boroxines in situ),[13] we were able to
demonstrate a remarkably broad reaction scope and unusu-
ally high functional-group compatibility (Table 1). With
respect to the oxadiazoline component, a variety of pharma-
ceutically relevant 4-, 5- and 6-membered saturated hetero-
cyclic examples were viable coupling partners, including
pyran (3a), tetrahydrofuran (3b), tetrahydrothiopyran (3c),
tetrahydrothiophene (3d), thietane (3e), N-Boc piperidine
(3 f), N-Boc pyrrolidine (3g), and N-Boc azetidine (3h) rings,
providing moderate to excellent yields of the desired C(sp2)@
C(sp3) cross-coupling products. It is particularly notable that
the 4-membered rings were viable examples given the
instability of 4-membered cyclic diazo compounds,[14] which
arises from the relief of ring strain when moving from an sp2
to an sp3 carbon center on reaction with electrophiles.
Furthermore, tolerance of the tetrahydrothiophene and
thietane moieties highlights examples where approaches
using a tosylhydrazone route or carbon-centered radical
approaches would fail, due to the tendency of these systems
to undergo elimination/ring-opening. A number of carbocy-
clic examples containing cycloalkyl groups (3 i–3 l) were also
permissible substrates, along with a highly hindered adaman-
tane substituent (3m). Tolerance of a cyclopropyl group (3n)
is not only indicative of a non-radical based process for this
C(sp2)@C(sp3) cross-coupling, but also further exemplifies the
advantages of this procedure over methods utilizing carbon-
centered radicals (where cyclopropane ring-opened products
would be obtained instead). In terms of functional-group
compatibility for the oxadiazoline component, olefins (3o),
alkynes (3p), acetals (3q), phosphonates (3r), sulfones (3s),
furans (3v), and pyrimidines (3w) were all viable substrates.
Remarkably, both an epoxide (3t) and an alkyl bromide (3u)
could participate in this coupling process, products that would
be intractable to access using metal-catalyzed methods or
harsh basic conditions. With respect to the boronic acid
component, a variety of electron-deficient aromatic rings
harboring various functional groups were suitable substrates,
including those with 4-bromo (3x), 4-trifluoromethyl (3y), 4-
Table 1: Metal-free protodeboronative and oxidative C(sp2)@C(sp3)
cross-coupling.
Yields stated are of isolated product. Protodeboronation: 0.5 mmol of
boronic acid, 1.0 mmol of oxadiazoline and 1.0 mmol of DIPEA, then
workup using TBAF (3 equiv.) and stirred further at RT for 16 h. *
protodeboronation was conducted at 75 8C for 16 h. Oxidation:
0.5 mmol of boronic acid, 1.0 mmol of oxadiazoline and 1.0 mmol of
DIPEA, then workup by stirring further under air at RT for 16 h.
Scheme 2. Oxadiazolines as diazo precursors and access to non-
stabilized diazo compound 2.
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cyano (3z), and 4-methoxycarbonyl (3aa) substituents. Elec-
tron-rich groups were also tolerated, including 3-acetamide
(3ab), 4-methoxy (3ac), and o-methyl (3ad) substituents,
although for the two latter cases, a higher temperature was
required to achieve protodeboronation. Although lower-
yielding, heterocyclic boronic acids could also be employed
in this method to provide useful amounts of desired cross-
coupled product, for example, 3-pyridyl (3ae) and 2-thienyl
(3af) substituents.
A simple switch in the workup procedure to stirring under
air provided the oxidized C(sp2)@C(sp3) cross-coupled prod-
ucts, and this reaction exhibited a similar broad scope and
high functional-group compatibility (Table 1).Again, a variety
of 4-, 5- and 6-membered saturated heterocyclic oxadiazolines
could be coupled with 4-chlorophenylboronic acid to generate
a variety of tertiary alcohols (4a–4h) in generally similar
yields to the protodeboronative method. Similar yields were
obtained for carbocyclic examples (4 i–4 l, 4n), with the
exception of adamantane derivative 4m, where oxidation
appeared to be extremely slow. In terms of functional-group
compatibility, olefins (4o), alkynes (4p), acetals (4q), phos-
phonates (4r), sulfones (4s), furans (4v) and pyrimidines
(4w) all proceeded smoothly. A particular highlight was the
tolerance of highly reactive functionalities such as an epoxide
(4t) and alkyl bromide (4u). Electron-poor boronic acids (4x,
4y) and electron-rich boronic acids (4ab) were also viable
coupling partners, although in the case of 4aa, protodeboro-
nation appeared to be facile and 30% of the protodebor-
onative C(sp2)@C(sp3) cross-coupled product 3aa was also
obtained. This overall method is complementary to conven-
tional Grignard addition but in many cases afforded products
that are not compatible with organometallic species.
To illustrate the utility of our newly developed method,
we first turned to the trapping of the tertiary boronic acid
derived from the coupling of 4-chlorophenylboronic acid and
the cyclobutane oxadiazoline precursor, using excess pinacol
as the final workup quench, which provided the valuable Bpin
product 5 in 74% yield (Scheme 3a). General methods to
access and assess the reactivity of these tertiary alkylboron
pinacol esters are vastly underdeveloped, so these examples
serve as testament to this versatile cross-coupling route, for
the synthesis of highly valued organoboron intermediates.
Utilization of 5 for the generation of valuable and pharma-
ceutically relevant tertiary cyclobutylamines was successfully
demonstrated, providing the benzyl protected derivative 6 in
70% yield over two steps.[15] Furthermore, we were also able
to construct quaternary carbon centers using two recently
developed methodologies for C(sp2)@C(sp3) cross-coupling of
boronic esters: reaction of 5 with 2-lithiofuran and a subse-
quent quench with N-bromosuccinimide (NBS) led to cyclo-
butylated furan derivative 7 in 47% yield;[16] whereas an
iridium-catalyzed photoredox flow process[17] allowed us to
couple 1-isoquinolinecarbonitrile to 5, leading to cyclobuty-
lated isoquinoline derivative 8 in 49% yield. Finally, we were
further able to apply this process to the short three-step
synthesis of the GABA receptor agonist drug, baclofen (10 ;
Scheme 3b).[18]
In summary, this work clearly demonstrates how oxadia-
zolines may be used as efficient, bench-stable precursors for
non-stabilized diazo compounds. Indeed, with these improve-
ments in metal-free C(sp2)@C(sp3) cross-coupling, this process
complements the well-established organometallic and orga-
nohalide cross-coupling procedures. In combination with
readily available arylboronic acids, this newly developed
flow method allows a myriad of potent, divergent, metal-free
C(sp2)@C(sp3) cross-coupling processes exhibiting a very
general reaction scope and unparalleled functional-group
tolerance, as well as access to new tertiary alkyl boronic
pinacol ester derivatives. Further applications of these
unstable diazo compounds are currently ongoing in our
laboratories.
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